Adage Capital Partners’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.5M Sell
1,108,586
-6,000
-0.5% -$83.9K 0.03% 509
2025
Q1
$15M Sell
1,114,586
-555,414
-33% -$7.49M 0.03% 483
2024
Q4
$32M Buy
1,670,000
+465,000
+39% +$8.91M 0.06% 311
2024
Q3
$27.4M Buy
+1,205,000
New +$27.4M 0.05% 371